Sort   by:  
 Page size 
UnknownMUC1-C is a target in lenalidomide resistant multiple myeloma.
Not available
S-EPMC5591051 | biostudies-literature
UnknownThe glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma.
Not available
S-EPMC4219442 | biostudies-literature
UnknownThe Multifaceted Role of Curcumin in Advanced Nanocurcumin Form in the Treatment and Management of Chronic Disorders.
Not available
S-EPMC8659038 | biostudies-literature
UnknownNutraceuticals and Herbs in Reducing the Risk and Improving the Treatment of COVID-19 by Targeting SARS-CoV-2.
Not available
S-EPMC8468567 | biostudies-literature
UnknownDNA methylation by DNMT1 and DNMT3b methyltransferases is driven by the MUC1-C oncoprotein in human carcinoma cells.
Not available
S-EPMC5121097 | biostudies-literature
UnknownInhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas.
Not available
S-EPMC4794417 | biostudies-literature
UnknownMUC1-C activates EZH2 expression and function in human cancer cells.
Not available
S-EPMC5547076 | biostudies-literature
UnknownMUC1-C Represses the Crumbs Complex Polarity Factor CRB3 and Downregulates the Hippo Pathway.
Not available
S-EPMC5136335 | biostudies-literature
UnknownTargeting MUC1-C suppresses polycomb repressive complex 1 in multiple myeloma.
Not available
S-EPMC5642475 | biostudies-literature
UnknownMUC1-C drives myeloid leukaemogenesis and resistance to treatment by a survivin-mediated mechanism.
Not available
S-EPMC6050463 | biostudies-literature
Sort   by:  
 Page size